170 filings
ARS
2023 FY
DTIL
Precision Biosciences Inc
25 Apr 24
Annual report to shareholders
4:35pm
DEFA14A
DTIL
Precision Biosciences Inc
25 Apr 24
Additional proxy soliciting materials
4:34pm
DEF 14A
DTIL
Precision Biosciences Inc
Definitive proxy
25 Apr 24
4:32pm
8-K
DTIL
Precision Biosciences Inc
16 Apr 24
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
4:47pm
10-K
2023 FY
DTIL
Precision Biosciences Inc
Annual report
27 Mar 24
7:15am
8-K
vksh 9f2w9xj79
27 Mar 24
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
7:15am
424B5
eebwh952rmab2dmx2
1 Mar 24
Prospectus supplement for primary offering
6:32pm
8-K
7tbbtw
1 Mar 24
Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants
8:00am
FWP
84f82iy6ofdr1mozupxx
1 Mar 24
Free writing prospectus
6:00am
424B5
41co1x1itpl0l 8o21o
29 Feb 24
Prospectus supplement for primary offering
5:19pm
8-K
3vltn
13 Feb 24
Amendments to Articles of Incorporation or Bylaws
8:29am
8-K
j1j0t6qb
23 Jan 24
Departure of Directors or Certain Officers
5:29pm
8-K
a2fpmd6u7z8674ojx4r
19 Jan 24
Submission of Matters to a Vote of Security Holders
7:30am
DEFA14A
70ldoq8g x3py
12 Jan 24
Additional proxy soliciting materials
8:00am
8-K
vl5ik khslhghkiuvt1
11 Jan 24
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
8:31am
8-K
7z2vn
22 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:12am
DEFA14A
mqade8 ph
4 Dec 23
Additional proxy soliciting materials
4:30pm
PRE 14A
k8y3r4q drx
22 Nov 23
Preliminary proxy
4:30pm